{
    "Trade/Device Name(s)": [
        "chromID\u2122 MRSA Agar",
        "chromID \u2122m MRSA agar",
        "chromlD \u2122m MRSA agar"
    ],
    "Submitter Information": "Biomerieux, Inc.",
    "510(k) Number": "K091024",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031018"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JSO"
    ],
    "Summary Letter Date": "July 17, 2009",
    "Summary Letter Received Date": "July 9, 2009",
    "Submission Date": "July 8, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.1700"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Methicillin-resistant Staphylococcus aureus (MRSA)"
    ],
    "Specimen Type(s)": [
        "Anterior nares swab"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Chromogenic medium",
        "Selective and differential culture"
    ],
    "Methodologies": [
        "Culture-based detection"
    ],
    "Submission Type(s)": [
        "Medium"
    ],
    "Document Summary": "FDA 510(k) summary for chromID MRSA Agar, a chromogenic medium for detecting MRSA colonization from anterior nares swabs.",
    "Indications for Use Summary": "Qualitative detection of nasal colonization by MRSA to aid in prevention and control of infections in healthcare settings; not for diagnosis or monitoring of MRSA infection.",
    "fda_folder": "Microbiology"
}